Xylem Inc (XYL)

From the record

Xylem Inc's filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Xylem Inc's 10 filed years say what it did: revenue went from $3.8 billion in fiscal 2016 to $9.0 billion in fiscal 2025, up 10.2% a year; it rose in 8 of 9 years; the deepest fall was 7% from fiscal 2019 to fiscal 2020; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Xylem Inc's diluted share count grew about 10.5% a year, and dividends and buybacks returned about 33% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 3 sales and 2 purchases of their own stock on the open market in the year to 2026-10-29, buying about $1 million (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Xylem Inc earned about 8 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 20 cents per dollar of everything the company owns. Leverage: it owed about 35 cents per dollar of assets, and net share issuance: its share count grew 0.2% over the year (the filed statements).

From the record

Xylem Inc's standing among 63 graded names in its industry family: revenue of $9.0 billion in fiscal 2025 ranks in the top 19% by size; a net margin of 10.6% ranks in the top 36%; revenue growth of 17.8% a year over the last 3 filed years ranks in the top 12% (its annual reports).

From the record

Xylem Inc's leadership, from its insiders' filings and its current reports: the chief executive on the record is Pine, Matthew Francis (Pres. & CEO, as filed), filing under that title since 2024-03-05, 2.7 years (bottom 27% of its family); the 21 officers and directors filing in the last fifteen months have been on the record a median of 3.8 years (bottom 16%); 5 officer or director changes were reported on Form 8-K since 2023-11-13, against the 21 people in charge now (top 17%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Xylem Inc's room to grow, from the newest filed statements (fiscal 2025): cash of $1.5 billion against debt of $1.4 billion leaves 0.4% of its assets as net cash, top 28% of its family; cash from operations less capital spending is 10.1% of revenue (top 39%); a gross margin of 38.5% (top 39%); research spending of 2.5% of revenue (bottom 41%) (its annual report).

From the record

Xylem Inc's growth drivers, from the filed years to fiscal 2025: revenue grew 17.8% a year over the last three filed years against 10.2% over all 10, speeding up (top 13% of its family); the newest year grew 5.5% (top 48%); research spending grew 3.1% a year (bottom 41%); capital spending grew 16.7% a year (top 23%) (its annual reports). Xylem Inc reported 2 product lines in fiscal 2025: Product at $7.5 billion (83%), Service at $1.6 billion (17%); 2 of 2 grew against the year before (its annual report).

From the record

Xylem Inc's newest year against its own record: revenue of $9.0 billion in fiscal 2025 came in 15.2% below the $11 billion its prior three years' pace pointed to (bottom 2% of its family); net income of $957 million against a prior three-year average of $618 million (top 29%); a net margin of 10.6% against 8.4% before (top 33%) (its annual reports).